Search research articles
Contact Us
Filters
Showing results (81-90 of 329) with videos related to
Page
of 33
Sort By:
Neurorehabilitation
|
November 29, 2013
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis
Roberta Ferrucci, Maurizio Vergari, Filippo Cogiamanian, et al.
Journal of Alzheimer'S Disease : JAD
|
May 3, 2021
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
Maria Serpente, Chiara Fenoglio, Andrea Arighi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2015
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis
Marco Vercellino, Chiara Fenoglio, Daniela Galimberti, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Circulating miRNAs as potential biomarkers in Alzheimer's disease
Daniela Galimberti, Chiara Villa, Chiara Fenoglio, et al.
Journal of Neurology
|
January 5, 2012
Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy
Laura Ghezzi, Andrea Arighi, Anna M Pietroboni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors
Laura Piccio, Barbara Rossi, Elio Scarpini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 24, 2010
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline
Cristoforo Comi, Miryam Carecchio, Annalisa Chiocchetti, et al.
Dementia and Geriatric Cognitive Disorders
|
March 31, 2016
Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia
Ilaria Cova, Francesca Clerici, Laura Maggiore, et al.
Neurobiology of Disease
|
December 19, 2006
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
Marzia Pesaresi, Sara Batelli, Francesca Prato, et al.
International Journal of Alzheimer'S Disease
|
June 11, 2011
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk
Letizia Polito, Francesca Prato, Serena Rodilossi, et al.
Page
of 33
Search research articles
Search
Showing results (81-90 of 329) with videos related to
Sort By:
Page
of 33
Neurorehabilitation
|
November 29, 2013
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis
Roberta Ferrucci, Maurizio Vergari, Filippo Cogiamanian, et al.
Journal of Alzheimer'S Disease : JAD
|
May 3, 2021
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
Maria Serpente, Chiara Fenoglio, Andrea Arighi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 9, 2015
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis
Marco Vercellino, Chiara Fenoglio, Daniela Galimberti, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Circulating miRNAs as potential biomarkers in Alzheimer's disease
Daniela Galimberti, Chiara Villa, Chiara Fenoglio, et al.
Journal of Neurology
|
January 5, 2012
Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy
Laura Ghezzi, Andrea Arighi, Anna M Pietroboni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 2, 2002
Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors
Laura Piccio, Barbara Rossi, Elio Scarpini, et al.
Journal of Alzheimer'S Disease : JAD
|
March 24, 2010
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline
Cristoforo Comi, Miryam Carecchio, Annalisa Chiocchetti, et al.
Dementia and Geriatric Cognitive Disorders
|
March 31, 2016
Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia
Ilaria Cova, Francesca Clerici, Laura Maggiore, et al.
Neurobiology of Disease
|
December 19, 2006
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
Marzia Pesaresi, Sara Batelli, Francesca Prato, et al.
International Journal of Alzheimer'S Disease
|
June 11, 2011
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk
Letizia Polito, Francesca Prato, Serena Rodilossi, et al.
Page
of 33